Clinical trial

A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors

NCT04397276

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-07-10

PhasePHASE1

Study timeline

Study start (actual)2020-07-10Date precision: day

Registry last updated2026-02-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Neoplasmsunresolved

Interventions

JNJ-70218902DRUG

Sponsors & collaborators

Janssen Research & Development, LLClead sponsor

Mapped research locations

MadridSpain2 TorontoOntario, Canada1 BarcelonaSpain1 VancouverBritish Columbia, Canada1 HaifaIsrael1 Tel AvivIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04397276 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.